What is Microbot Medical Inc (MBOT) stock price today?

Microbot Medical Inc (MBOT) currently trades at $2.04 per share. The stock has a market capitalization of $137.00M and a P/E ratio of —x.

Is MBOT stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Microbot Medical Inc has a Smart Value Score of 35/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is -27.66.

Is Microbot Medical Inc financially healthy?

Microbot Medical Inc's Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of -27.66 places it in the distress.

MBOT

Microbot Medical Inc

NASDAQ: MBOT · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$2.04

-2.86% today

Updated 2026-04-29

Market cap

$137.00M

P/E ratio

—

P/S ratio

73.89x

EPS (TTM)

$-0.29

Dividend yield

—

52W range

$2 – $5

Volume

1.8M

Market cap

$137.00M

P/E ratio

—

P/S ratio

73.89x

EPS (TTM)

$-0.29

Dividend yield

—

52W range

$2 – $5

Volume

1.8M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

4.3

Growth

6.5

Quality

3.0

Profitability

6.0

Valuation

2/9

Piotroski F-Score

Weak

-27.7

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$7.50

+267.65%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.01x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Altman Z -27.66 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-3.78M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-13.17M	$-10.74M	$-11.44M	$-13.14M	$-3.46M
EPS	—	—	—	—	$-0.29
Free cash flow	$-11.63M	$-8.57M	$-8.85M	$-13.11M	$-3.78M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
MBOT	$137.00M	35	4.3	3.0	6.0	6.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Microbot Medical Inc trades at $2.04. Our Smart Value Score of 35/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -27.66, it sits in the distress.

Frequently asked questions

What is Microbot Medical Inc's stock price?

Microbot Medical Inc (MBOT) trades at $2.04.

Is Microbot Medical Inc overvalued?

Smart Value Score 35/100 (Grade D, Sell).

What is the price target of Microbot Medical Inc (MBOT)?

The analyst target price is $7.50, representing +267.6% upside from the current price of $2.04.

Piotroski F-Score?

2/9 — weak financial health.

Altman Z-Score?

-27.66 — distress.

Company info

SectorHEALTHCARE

IndustryMEDICAL INSTRUMENTS & SUPPLIES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

microbotmedical.com

Quick metrics

P/S ratio73.89x

ROE-32.40%

Beta1.19

50D MA$2.41

200D MA$2.55

Shares out0.07B

Float0.07B

Short ratio—

Avg volume1.8M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

MBOT vs LLY →MBOT vs JNJ →MBOT vs ABBV →Stock screener →